Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis

By afschroeder • February 3, 2026

Karpouzas GA, Pascual-Ramos V, Gonzalez-Gay MA, Misra DP, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Galarza-Delgado D, Van Riel P, Semb AG, Hauge EM, Kitas GD, Ormseth SR; An inTernationAl Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis. RMD Open. 2026 Feb 2;12(1):e006420. doi: 10.1136/rmdopen-2025-006420. PMID: 41629127.

Tags: Arthritis, autoantibodies, cardiovascular diseases, Harbor UCLA, Inflammation, Publications, Rheumatoid, Rheumatology

Efficacy and safety of relacorilant for the treatment of patients with Cushing’s syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study

Pivonello R, Arnaldi G, Auchus RJ, Badiu C, Busch RS, Cannavò S, Dischinger U, Dobri GA, Donegan DM, Elenkova A, Fazeli PK, Feelders RA, Garcia-Centeno[...]

A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid and Lymphoid Leukemias

Chan B, Balar E, Villalona S, Karp J, Leahy A, Lai C. A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid[...]

Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis

Razavi AC, Bhatia HS, Marrero N, Dzaye O, Post WS, Nasir K, Tsai M, Vaccarino V, Vasan RS, Thanassoulis G, Tsimikas S, Sperling LS, Budoff[...]